Effect of Nigella sativa extraction supplement in benign prostatic hyperplasia

Phase 2

Recruiting

• Conditions: Benign prostatic hyperplasia.; Benign neoplasm of prostate; D29.1

• Registration Number: IRCT20201108049311N4
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 November 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: Male
• Target Recruitment: 60

Inclusion Criteria

Having benign prostate hyperplasia with or without lower urinary tract symptoms
Eligible to participate in the study

Exclusion Criteria

Presence of possible allergy to Nigella sativa extraction supplement

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluation of urinary problems. Timepoint: At first, 2, 4 and 8 weeks after the drug intervention. Method of measurement: Designed IPSS questionnaire.;Measuring the prostatic volume. Timepoint: At first, 2, 4 and 8 weeks after the drug intervention. Method of measurement: Evaluation of ultrasound results.

Secondary Outcome Measures

Name	Time	Method
Measuring the remained urine volume. Timepoint: At first, 2, 4 and 8 weeks after the drug intervention. Method of measurement: Evaluation of ultrasound results.;Evaluating prostatic specific antigen (PSA) level. Timepoint: At first, 2, 4 and 8 weeks after the drug intervention. Method of measurement: ELISA test from blood samples.